Quantcast

On January 7, 2005, Abraxane gained FDA approval in MBC

We thank you for
10 years of inspiration

Building on a decade of support and commitment,

Celgene continues its dedication
to patients with MBC

Recognizing 10 years of real-world clinical experience
in metastatic breast cancer.

Abraxane is inspired by those
affected by MBC and will continue
to be a committed ally in this fight.

US-ABR140058a(1)a01/15